Herborium Group Inc. (OTCMKTS:HBRM) Stock Falls: Surpasses Million Dollar Sales Mark
Herborium Group Inc. (OTCMKTS:HBRM) dropped 12%, but it is up 75% in a week. The Botanical Therapeutics Firm and unique botanical medicinal, wellness, and beauty products provider have announced that it ended 2021 with sales surpassing $1 million as per its 2021 Annual Report.
Market Stats
On Tuesday, HBRM stock slumped 12.50% to $0.0003 with more than 68.39 million shares, compared to its average volume of 49.16 million shares. The stock moved within a range of $0.0003 – 0.0004 after opening trading at $0.0004.
Key Analysis
This will be the fifth consecutive year the company is posting positive revenues. Notably, the positive trend extended to Q1 2022, which shows that the company anticipates high sales in Q1 2022.
Additionally, the company reduced its debt considerably by doing away with Notes Debt of almost $250,000. As a result, this minimizes the possibility of dilution in the future, which is crucial in the company’s effort to increase its share price.
Lastly, Herborium secured and kept its high status on OTC Pink Current Information. The company is expecting sales growth to continue this year through the special projects and several changes that will be announced shortly. Therefore, HBRM is worth keeping an eye on in the coming weeks.
Traders Corner
HBRM stock is trading below the 20-Day and 50-Day Moving averages of $0.0003 and $0.0003 respectively. Moreover, the stock is trading below the 200-Day moving average of $0.0006.
